Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drugAntônio Waldo Zuardi, Francisco Silveira Guimarães, J.A.S. Crippa et al.|Brazilian Journal of Medical and Biological Research|2006Cited by 410
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real LifeAntônio Waldo Zuardi, José A. Crippa, Natália Pegoraro Rodrigues et al.|Frontiers in Pharmacology|2017Cited by 291
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational InvestigationAntônio Waldo Zuardi, Francisco Silveira Guimarães, Zerrin Atakan et al.|Current Pharmaceutical Design|2012Cited by 222
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophreniaCristiano Chaves, Jorge Hallak, Cristiane Reberte de Marque et al.|Schizophrenia Research|2014Cited by 41
Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophreniaLudmyla Kandratavicius, Jaime E. C. Hallak, Priscila Alves Balista et al.|BMC Neuroscience|2015Cited by 40